INS and cancer: On 26th June 2009, four articles were published on-line in Diabetologia: one each from Germany [Hemkens et al, 2009], Sweden [Jonasson et al, 2009], Scotland [SDRN, 2009] and England [Currie et al, 2009] which were interpreted in an accompanying Editorial [Smith and Gale, 2009] of demonstrating that the risk of cancer was increased among patients being treated with glargine insulin for their type II diabetes.